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a b s t r a c t
We previously established a long-lasting cystitis model by an intravesical injection of hydrogen peroxide
(H2O2) into mice. In this study, we assessed the pain-related behaviors in the cystitis model. An intra-
vesical injection of 1.5% H2O2 transiently decreased spontaneous locomotor activity at 3 h after injection,
indicative of acute spontaneous pain. In contrast, licking response to a bladder distention was slowly
observed as licks to the lower abdomen at 7 and 14 days after injection, which was attenuated by
amitriptyline and morphine, but not by oxybutynin. These results suggest that H2O2-induced chronic
cystitis model shows delayed and long-lasting painful pathological condition.
© 2015 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Chronic inﬂammation in the urinary bladder generally causes
urinary frequency, urgency, nocturia and pelvic or lower abdominal
pain (1). Chronic inﬂammatory bladder diseases, such as interstitial
cystitis/bladder pain syndrome (IC/BPS), are caused by infectious
and noninfectious etiology. However, there are little or no reliably
effective therapies and drugs for IC/BPS (2). For the current therapy
to relieve BPS, tricyclic antidepressants, nonsteroidal antiin-
ﬂammatory drugs (NSAIDs) and opioids are used for BPS (3, 4),
although their analgesic efﬁcacies are limited. BPS has been eval-
uated in a variety of experimental cystitis animal models, such as
cyclophosphamide-induced cystitis model (5). However, since
these models are characterized as acute inﬂammation, the dura-
tions of pain-related behaviors are usually short, which disagree
with the pathology of chronic cystitis.
We recently established a cystitis mouse model induced by
hydrogen peroxide (H2O2), which showed relatively long-lasting
inﬂammatory and overactive bladder. An intravesical (i.ves.) in-
jection of H2O2 increased the number of voids and bladder weight
by 1 day and lasted up to 7 days after the injection, which was
longer than that in existing cystitis models. In this model, initial
H2O2-induced urothelial damage and hyperpermeability are
considered to trigger long-lasting bladder inﬂammation (6). Thus,
the H2O2-induced cystitis is a simple and useful model for chronic
cystitis. However, pain-related behaviors in this model remained to
be clariﬁed. In cyclophosphamide-induced cystitis model mice,
bladder pain-like spontaneous nociceptive behaviors, such as
licking and biting to the lower abdomen close to the bladder, and
referred hyperalgesia assessed by von Frey ﬁlaments (7). However,
we could not detect such bladder pain-like behaviors in the H2O2-
induced cystitis model mice (preliminary data). In this study, we
examined two types of pain-related behaviors, including the
reduced spontaneous locomotor activity and the bladder
distension-evoked licks to the lower abdomen, in the H2O2-induced
cystitis model mice.
This study was carried out in accordance with the recommen-
dations in the Guiding Principles for the Care and Use of The Jap-
anese Pharmacological Society. The protocol was approved by the
Kyoto University Animal Research Committee. Female C57BL/6J
mice aged between 5 and 6weeks-old (Japan SLC, Shizuoka) were
housed under constant ambient temperature (24 ± 1 C) and
lightedark cycle with feeding ad libitum.
H2O2-induced cystitis model was made as described previously
(6). Brieﬂy, under 2e3% isoﬂurane anesthesia, 50 mL of saline or 1.5%
H2O2 saline solution was injected into the bladder through a
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catheter. The H2O2 solution was drained from the bladder after
30 min.
For the measurement of locomotor activity, mice were allowed
to habituate to the experimental condition in an individual clear
plastic cage (10 cm W  20 cm L  30 cm H) for 30 min, and the
behaviors were videotaped for 15 min. Move distance, average
speed of movement, and freezing time were analyzed using ANY-
maze™ (Stoelting Co., USA).
For the measurement of bladder distension-evoked pain-related
behavior, mice were habituated to the experimental condition in
the plastic cage for 30min. Under 2e3% isoﬂurane anesthesia, 50 mL
of saline was injected into the bladder through a catheter. Mice
were kept for 1 min under 1% isoﬂurane anesthesia, and the be-
haviors were videotaped under fresh air condition. After the re-
covery from anesthesia, the time spent in licking of the lower
abdomenwasmeasured for 20min. To examine the effects of drugs,
oxybutynin chloride, indomethacin (SigmaeAldrich Japan, Tokyo),
amitriptyline hydrochloride (LKT Laboratories Inc., USA) or
morphine hydrochloride (Takeda Pharmaceutical Co., Osaka) was
freshly dissolved in a saline containing 5% DMSO and 2% Tween80.
One of these drugs was administered intraperitoneally (i.p.) 30 min
before the test. The doses of drugs were chosen so that they inhibit
frequent urination in the H2O2-induced cystitis model (6).
All data are presented as the mean ± S.E.M. Statistical signiﬁ-
cance was calculated by two-way analysis of variance (ANOVA), or
two-way ANOVA for repeated measures, followed by Bonferroni
post hoc test.
Reduced locomotor activity in rodents is proposed as sponta-
neous visceral pain-related behavior, as previously reported in
cyclophosphamide-induced cystitis model mice (7). In this study,
we examined the effect of i.ves. injection of H2O2 on the sponta-
neous locomotor activity (Fig. 1). An i.ves. injection of 1.5% H2O2
signiﬁcantly increased the freezing time (F1,40 ¼ 13.84, P < 0.001),
and decreased the move distance (F1,40 ¼ 6.26, P < 0.05) and
average speed (F1,40¼ 5.67, P < 0.05), although i.ves. saline injection
had no effect. The signiﬁcant differences were observed only at 3 h
(freezing time, move distance and average speed) and 1 day (move
distance) after H2O2 injection. They recovered gradually from the
next day and to the control level 7 days after the injection.
To assess the delayed phase of pain-related behaviors in the
H2O2-induced cystitis model, the effect of bladder distension was
examined. An i.ves. injection of 50 mL of saline evoked licking of the
lower abdomen. The time spent in licking was signiﬁcantly
increased in H2O2-induced cystitis model mice (F1,57 ¼ 12.17,
P< 0.001). The signiﬁcant increases were observed at 7 and 14 days,
but not at 1 day, after H2O2 injection, compared with that in control
mice (Fig. 2A).
We examined the effects of therapeutic drugs on the bladder
distension-evoked licking 7 days after H2O2 injection (Fig. 2B).
Amitriptyline (1 mg/kg) or morphine (3 mg/kg) signiﬁcantly
attenuated the increased licking time, compared with the i.p.
vehicle-administered group. Indomethacin (3 mg/kg) tended to,
but not signiﬁcantly, attenuate the increased licking time, while
oxybutynin (3 mg/kg) had no effect. In i.ves. saline-injected control
mice, each drug had no signiﬁcant effect on the licking time,
although oxybutynin and indomethacin slightly tended to increase
it.
In this study, we assessed two types of pain-related behaviors in
the H2O2-induced cystitis model mice. The decreased locomotor
activity is consistent with the previous report in
cyclophosphamide-induced cystitis model (8). However, the
hypolocomotion was observed only within 1 day after the H2O2
injection, suggesting acute pain-related behavior. In the acute
phase of this model, H2O2 destroyed bladder urothelium leading to
severe acute inﬂammation accompanied with bladder urothelial
and vascular hyperpermeabilities, edematous thickening in the
lamina propria, inﬁltration of inﬂammatory cells, and production of
inﬂammatory cytokines (6). These severe damages in the bladder
may immediately evoke the hypolocomotion, and recover with the
restoration of bladder tissue within several days. Furthermore, we
could not detect refereed hyperalgesia.
By contrast, bladder distension-evoked licking was observed in
the delayed phase of H2O2-induced cystitis model, which was
attenuated by analgesics, suggesting delayed and long-lasting pain-
related behavior. Consistent with the ﬁndings that, anticholinergic
drugs alleviate urinary and bladder dysfunction (9), oxybutynin
reduces the urinary frequency in this model (6), but shows neither
anti-inﬂammatory nor analgesic effect. Unlike other cystitis
models, following the recovery of bladder damages, bladder
inﬂammation is prolonged, and the remodeling and hyperplasia of
the bladder urothelium occur (6). Inﬂammatory cytokines induce
the hypersensitivity of the bladder sensory nerves leading to
bladder overactivity (10). Thus, it is suggested that hyperplastic
urothelium following the recovery of bladder damages and hy-
persensitivity of the bladder sensory nerves may contribute to the
delayed and long-lasting pain-related behavior. On the other hand,
prostaglandins are released immediately after synthesis from the
urothelium of overactive bladder models in response to the bladder
distension (11). However, the present results that the analgesic
effect of an NSAID was weak suggest that the pain-related behavior
is not merely mediated through prostaglandin synthesis and
Fig. 1. Effects of an intravesical injection of H2O2 on the spontaneous locomotor ac-
tivities. Mice were injected intravesically (i.ves.) with saline or 1.5% H2O2. Three hours,
1, 7 and 14 days after the injection, freezing time (A), move distance (B) and average
speed (C) were measured for 15 min n ¼ 6. *P < 0.05, ***P < 0.001, compared with i.ves.
saline-injected control mice.
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bladder inﬂammation, consistent withminimal evidence of chronic
inﬂammation in non-ulcer type IC/BPS patients (12). It is possible
that initial severe painful stimuli and chronic bladder inﬂammation
might lead to the central sensitization of pain pathway in the spinal
cord and brain, resulting the delayed and long-lasting bladder pain
(13). It is noted that the licking of lower abdomen by i.ves. saline
injection may represent urethra pain rather than bladder pain, as
previously noted (14).
In conclusion, the present study revealed that H2O2-induced
chronic cystitis model shows delayed and long-lasting painful
pathological condition. This model may help to study chronic
bladder pain in chronic cystitis such as IC/BPS.
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Fig. 2. Bladder distension-evoked licking to lower abdomen in H2O2-induced cystitis
model. (A) Mice were injected intravesically (i.ves.) with saline or 1.5% H2O2. 1, 7 and 14
days after the injection, mice were injected with 50 mL of saline to dilate bladder. After
the recovery from anesthesia, the time spent licking of the lower abdomen was
measured for 20 min n ¼ 6e15. *P < 0.05, **P < 0.01, compared with i.ves. saline-
injected control mice. (B) Effects of therapeutic drugs on the increased total licking
time in H2O2-induced cystitis model mice. Seven days after the i.ves. saline or 1.5%
H2O2 injection, oxybutynin (3 mg/kg), indomethacin (3 mg/kg), amitriptyline (1 mg/
kg), morphine (3 mg/kg) or vehicle was given intraperitoneally 30 min before testing.
The licking time was measured for 20 min n ¼ 7e13. ***P < 0.001, N.S. ¼ not signiﬁcant.
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